Hippocratic AI, a generative AI company specializing in safety-focused large language models for healthcare, recently closed a $141 million Series B funding round, bringing its valuation to $1.64 billion. Led by Kleiner Perkins, the round included notable investors such as NVIDIA, General Catalyst, and a16z. The company focuses on non-diagnostic healthcare tasks like medication onboarding, policy questions, and EHR assistance. Alongside the funding news, Hippocratic AI launched its Healthcare AI Agent App Store, enabling clinicians to collaborate in designing AI agents tailored to specific patient care needs and workflow improvements. These agents, safety-tested by clinicians and Hippocratic AI, can be created in under 30 minutes, emphasizing the company’s commitment to clinician involvement in AI development.
Since its launch in May 2023, Hippocratic AI has rapidly expanded its funding and offerings. The company initially raised $50 million in seed funding and subsequently garnered additional investments, achieving a valuation of $500 million by the end of its Series A round. Beyond financial growth, it has developed advisory councils to ensure safety in its AI solutions and partnered with Adtalem Global Education to create a curriculum for clinician AI training. With the Series B funding, the company plans to expand into new markets, including pharmaceuticals and payors, and enter regions such as EMEA, Latin America, and Southeast Asia. Its recent patent for a constellation architecture called Polaris further solidifies its innovation in safety-focused healthcare AI.